Meloxicam/rizatriptan, sold under the brand name Symbravo, is a fixed-dose combination medication used for the treatment of migraine. It is a combination of meloxicam, a nonsteroidal anti-inflammatory medication; and rizatriptan, a serotonin (5-HT) 1B/1D receptor agonist (triptan). It is taken by mouth.